• Cytoskeleton-Dependent Autophagy Under Mechanical Stress

  2026-07-20

  This study establishes that cytoskeletal microfilaments are essential for autophagy induction by mechanical stress in human cells. By dissecting the relative roles of microfilaments and microtubules, the research clarifies mechanotransduction pathways critical for cellular homeostasis and signal transduction.

• EPZ5676: Advanced DOT1L Inhibitor Workflows for Epigenetic R

  2026-07-20

  EPZ5676 redefines selective DOT1L inhibition, empowering researchers to dissect H3K79 methylation and target MLL-rearranged leukemias with precision. Its nanomolar potency and robust selectivity streamline both cancer and fibrosis models, unlocking new experimental possibilities.

• Genistein in Cytoskeleton-Dependent Autophagy and Cancer Res

  2026-07-19

  Explore how Genistein, a 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one, enables advanced interrogation of cytoskeleton-mediated autophagy and cancer chemoprevention. This article offers a unique, practical perspective for experimental design and assay optimization.

• 2-D08 and the Future of Precision SUMOylation Inhibition

  2026-07-18

  This article explores the transformative role of 2-D08 (2’,3’,4’-trihydroxyflavone) in advancing our understanding and strategic application of sumoylation inhibition in translational research. By weaving mechanistic insights with actionable guidance and recent breakthroughs—such as the modulation of mitophagy in bronchopulmonary dysplasia—the article positions 2-D08 as a critical tool for dissecting posttranslational modification pathways in cancer and mitochondrial disease models.

• NMDA (N-Methyl-D-aspartic acid) in Excitotoxicity Research

  2026-07-17

  NMDA (N-Methyl-D-aspartic acid) enables precision modeling of neuronal injury and oxidative stress in neurodegeneration and stem cell transplantation studies. This guide translates the latest reference breakthroughs into actionable workflows, troubleshooting strategies, and comparative insights for advanced neuroscience labs.

• G-15 as a Precision Tool for Neuropathic Pain Circuitry Rese

  2026-07-17

  Explore how G-15, a selective G protein-coupled estrogen receptor antagonist, is revolutionizing neuropathic pain research by enabling highly specific dissection of GPR30-mediated neural circuits. This article offers novel insights into intracellular calcium mobilization assays and practical assay design, drawing on recent high-impact neuroscience findings.

• Annexin-V Imaging of Cardiomyocyte Death in Ischemia/Reperfu

  2026-07-16

  The reference study demonstrates the use of labeled recombinant human annexin-V for in situ visualization of early cardiomyocyte death following ischemia and reperfusion (I/R) in mouse hearts. By quantifying phosphatidylserine externalization, the research defines the time frame of cell death and provides a robust assay for evaluating cell death–blocking interventions, informing future experimental design in cardiovascular injury research.

• Pentoxifylline Attenuates Hyperinflammation in Preterm Monoc

  2026-07-16

  This study demonstrates that pentoxifylline, a non-specific phosphodiesterase inhibitor, significantly downregulates LPS-induced inflammatory activation in monocytes from preterm infants in vitro. The findings clarify age-dependent immunomodulatory mechanisms relevant for neonatal sepsis research and highlight specific molecular targets for intervention.

• Tetrandrine Alkaloid: Reliable Solutions for Cell-Based Assa

  2026-07-15

  This article provides scenario-driven guidance for biomedical researchers using Tetrandrine (SKU N1798) in cell viability, ion channel modulation, and inflammation studies. It addresses workflow compatibility, protocol optimization, and data interpretation, highlighting the reproducibility and quality advantages of Tetrandrine from APExBIO.

• 4-MUG: Enabling Next-Gen Lysosomal and Gaucher Disease Resea

  2026-07-15

  This in-depth thought-leadership article explores the mechanistic and translational value of 4-Methylumbelliferyl-β-D-Glucopyranoside (4-MUG) in lysosomal enzyme research, focusing on Gaucher disease and mRNA-based therapeutic innovation. By integrating the latest findings, practical protocol guidance, and strategic considerations for translational scientists, we chart a path from advanced assay design to future clinical impact.

• MPC-Driven Lactate, Histone Lactylation, and Tumor Immunity

  2026-07-14

  This study reveals how mitochondrial pyruvate carrier (MPC) downregulation in colorectal cancer drives excess lactate production, leading to histone lactylation in dendritic cells and suppression of antitumor immunity. The findings highlight a novel epigenetic mechanism linking tumor metabolism to immune evasion, with implications for immunotherapy strategies.

• Cytochalasin B (NSC 107658): Precision Tools for Translation

  2026-07-14

  Explore how Cytochalasin B (NSC 107658) empowers translational researchers to dissect actin-driven cell processes relevant to drug discovery and cytotoxicity evaluation. This thought-leadership article integrates mechanistic insights, protocol guidance, and strategic outlooks with evidence from genotoxicity studies and emerging workflow advances.

• Ribonuclease R (RNase R): Precision Tools for DNA Damage & I

  2026-07-13

  Explore how Ribonuclease R (RNase R) (20 U/μL) enables targeted linear RNA degradation, advancing circular RNA enrichment and revealing new insights into DNA damage and inflammation pathways. Discover protocols and applications distinct from existing content.

• Acifran: Precision Agonist for Lipid Metabolism Research Wor

  2026-07-13

  Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid) enables unparalleled specificity in lipid signaling pathway modulation and metabolic disorder research. Drawing on cryo-EM structural insights, this guide details optimized workflows, troubleshooting strategies, and practical advances for translational scientists using Acifran.

• Refining In Vitro Assays for Drug Response in Cancer Researc

  2026-07-12

  Schwartz's dissertation introduces a rigorous framework for distinguishing between drug-induced proliferative arrest and cell death in cancer cell assays. By dissecting these distinct endpoints, the work clarifies how in vitro methods can more accurately characterize anticancer drug responses, directly informing the design and interpretation of functional studies.

8376 records 7/559 page Previous Next First page 上5页 678910 下5页 Last page